Heard on the Street: A blood test that could screen for dozens of cancers at once moved closer when an FDA panel backed Grail’s Galleri multi-cancer test

An FDA panel backed Grail’s Galleri test. But the Medicare money the business depends on is far from guaranteed.

Discover more from RealUS.news

Subscribe now to keep reading and get access to the full archive.

Continue reading